Lataa...
Blood Glucose Variations and Clinical Experience with Glibenclamide in Diabetes Mellitus
Thirty patients were treated with glibenclamide for periods up to 16 months. The drug is a potent hypoglycaemic agent, and taken in a single daily dose controls blood glucose levels over a 24-hour period in maturity onset diabetes. A definite dose-effect relationship exists, and the drug may be used...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1970
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1700211/ https://ncbi.nlm.nih.gov/pubmed/5526612 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|